Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD26/DPP4 - a potential biomarker and target for cancer therapy
Njanja Enz, Gwendolyn Vliegen, Ingrid De Meester, et al.
Pharmacology & Therapeutics (2019) Vol. 198, pp. 135-159
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury
Lingming Kong, Jie Deng, Xiang Zhou, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 138
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
Julia M. Houthuijzen, Roebi de Bruijn, Eline van der Burg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
Han-jie Liu, Huimin Hu, LI Guan-zhang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 134
Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6151-6151
Open Access | Times Cited: 91
Preparation and identification of dipeptidyl peptidase IV inhibitory peptides from quinoa protein
Haixi You, Tianliang Wu, Wei Wang, et al.
Food Research International (2022) Vol. 156, pp. 111176-111176
Closed Access | Times Cited: 51
Targeting purine metabolism in ovarian cancer
Jingchun Liu, Shasha Hong, Yang Jiang, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 50
A CD26+ tendon stem progenitor cell population contributes to tendon repair and heterotopic ossification
Siwen Chen, Yingxin Lin, Hao Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 18
A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets
Chiao-Wei Lin, Ting-Wei Huang, Yu-Ju Peng, et al.
Poultry Science (2020) Vol. 100, Iss. 3, pp. 100869-100869
Open Access | Times Cited: 42
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer
Yingchun Liang, Fangdie Ye, Chenyang Xu, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
Jiahang Song, Liu Yan-hu, Xiang Guan, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 38
CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
Emi Kawakita, Daisuke Koya, Keizo Kanasaki
Cancers (2021) Vol. 13, Iss. 9, pp. 2191-2191
Open Access | Times Cited: 35
A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients
Yikang He, Yangfan Ye, Wei Tian, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
Petr Bušek, Jonathan S. Duke‐Cohan, Aleksi Šedo
Cancers (2022) Vol. 14, Iss. 9, pp. 2072-2072
Open Access | Times Cited: 27
DPP4 as a Potential Candidate in Cardiovascular Disease
Siyu Chen, Kong Xiangquan, Ke-Fan Zhang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 5457-5469
Open Access | Times Cited: 23
Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization
Ya Hui, Zhiqiang Xu, Jiaxiu Li, et al.
Metabolism (2022) Vol. 138, pp. 155340-155340
Closed Access | Times Cited: 23
Intestinal Immune Imbalance is an Alarm in the Development of IBD
C.C. Hu, Shengtao Liao, Lin Lv, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 16
Epigallocatechin gallate alleviates Non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4
Mingfeng Yang, Ruike Yan, Ruohe Sha, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 8, pp. 1769-1780
Closed Access | Times Cited: 5
Air pollution and prostate cancer: Unraveling the connection through network toxicology and machine learning
Yuqi Li, Tao Zhou, Zhiyu Liu, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117966-117966
Open Access
Renoprotective Effects of DPP-4 Inhibitors
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 28
Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1/DPP4 axis in hepatocellular carcinoma
Jiwei Zhang, Tao Pan, Weiwei Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 22
Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases
Xiaopeng Hu, Xisheng Wang, Xingkui Xue
Molecules (2022) Vol. 27, Iss. 14, pp. 4498-4498
Open Access | Times Cited: 20
Ferroptosis: a potential therapeutic target for Alzheimer’s disease
Lan Yang, Jianfei Nao
Reviews in the Neurosciences (2022) Vol. 34, Iss. 5, pp. 573-598
Closed Access | Times Cited: 19
Sniping Cancer Stem Cells with Nanomaterials
Wen-Da Wang, Yanyu Guo, Zhonglu Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23262-23298
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top